Evidence map›Paper›PMID 17111046›Full record

ArticleThe Journal of clinical investigation2006

Indoleamine 2,3-dioxygenase-expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection.

Alexey Popov, Zeinab Abdullah, Claudia Wickenhauser, Tomo Saric, Julia Driesen, Franz-Georg Hanisch, Eugen Domann, Emma Lloyd Raven, Oliver Dehus, Corinna Hermann and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 149 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Molecular pathogenesis ofMicrobiology and molecular biology reviews : MMBR · 2025
    Review
  5. Observational
  6. Review
  7. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Innate Lymphoid Cells in Response to Intracellular Pathogens: ProtectionFrontiers in cellular and infection microbiology · 2021
    Review
  17. Review
  18. Review
  19. Article
  20. Crosstalk between cancer-associated fibroblasts and immune cells in cancer.Journal of cellular and molecular medicine · 2020
    Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 2 countries.

Alexey PopovMolecular Tumor Biology and Tumor Immunology at the Clinic I for Internal Medicine, University of Cologne, Cologne, Germany.
Zeinab Abdullah
Claudia Wickenhauser
Tomo Saric
Julia Driesen
Franz-Georg Hanisch
Eugen Domann
Emma Lloyd Raven
Oliver Dehus
Corinna Hermann
Daniela Eggle
Svenja Debey
Trinad Chakraborty
Martin Krönke
Olaf Utermöhlen
Joachim L Schultze
Institute of Medical Microbiology and Hygiene · DEUniversity of Giessen · DEUniversity of Konstanz · DEUniversity of Cologne · DEUniversity of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Control of pathogens by formation of abscesses and granulomas is a major strategy of the innate immune system, especially when effector mechanisms of adaptive immunity are insufficient. We show in human listeriosis that DCs expressing indoleamine 2,3-dioxygenase (IDO), together with macrophages, are major cellular components of suppurative granulomas in vivo. Induction of IDO by DCs is a cell-autonomous response to Listeria monocytogenes infection and was also observed in other granulomatous infections with intracellular bacteria, such as Bartonella henselae. Reporting on our use of the clinically applied anti-TNF-alpha antibody infliximab, we further demonstrate in vitro that IDO induction is TNF-alpha dependent. Repression of IDO therefore might result in exacerbation of granulomatous diseases observed during anti-TNF-alpha therapy. These findings place IDO(+) DCs not only at the intersection of innate and adaptive immunity but also at the forefront of bacterial containment in granulomatous infections.

Indexed as

Antigens, CDAntigens, Differentiation, MyelomonocyticCD3 ComplexCD68 MoleculeCells, CulturedCyclooxygenase 2Dendritic CellsEnzyme-Linked Immunosorbent AssayGene ExpressionGranulomaHumansImmunoblottingImmunohistochemistryIndoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaLewis X AntigenAntigens, CDAntigens, Differentiation, MyelomonocyticCD3 ComplexCD68 antigen, humanCD68 MoleculeCyclooxygenase 2Indoleamine-Pyrrole 2,3,-DioxygenaseInterferon-gammaLewis X AntigenMembrane ProteinsPTGS2 protein, humanS100 ProteinsTumor Necrosis Factor-alpha

Identifiers

PMID17111046
PMCPMC1636691
OpenAlexW2142098035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.